decreased circulating triglyceride level_Apobec1<tm1Chan>/Apobec1<tm1Chan>,Tg(CETP)5203Tall/0

http://metadb.riken.jp/0002644I129S4SvJaeC57BL6JCBAJApobec1tm1ChanApobec1tm1ChanTgCETP5203Tall0TgCETP5203TallApobec1tm1Chan

decreased circulating triglyceride level_Apobec1<tm1Chan>/Apobec1<tm1Chan>,Tg(CETP)5203Tall/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:103298
• transgene insertion 5203, Alan Tall
  http://metadb.riken.jp/db/mgi_rdf/MGI:3505692

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apobec1<tm1Chan>/Apobec1<tm1Chan>,Tg(CETP)5203Tall/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(CETP)5203Tall|Apobec1<tm1Chan>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae * C57BL/6J * CBA/J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating triglyceride level
  http://purl.obolibrary.org/obo/MP_0002644

文献

http://purl.org/net/cito/citesAsAuthority

• M. Nakamuta, et.al., Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression., Arteriosclerosis, thrombosis, and vascular biology, 1998, 18
  http://rdf.ncbi.nlm.nih.gov/pubmed/9598833